| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
In this study we undertook to provide evidence for local in vivo isotype switching to IgE following nasal
challenges. Detection of deleted switch circular DNA (switch circles) by a novel nested polymerase chain
reaction-based approach was employed as definitive molecular evidence of Ig isotype switching. Nasal
challenge in humans with diesel exhaust particles (DEP) plus ragweed antigen has been shown to enhance
local IgE production, stimulate local cytokine production, and markedly increase mucosal IgE antibody to
ragweed. Four days after combined intranasal DEP plus ragweed challenge, we detected and characterized
clones of deleted switch circular DNA (S
/Sµ) representing switching from µ to
from nasal lavage cells.
No switch circular DNA was detected in nasal lavage cells following challenge with DEP alone nor with
ragweed allergen alone. These results indicate that the combination of mucosal stimulation with DEP and
ragweed allergen is capable of driving in vivo isotype switching to IgE in humans with ragweed allergy.
These results are the first direct demonstration of in vivo IgE isotype switching in humans.
| |
Introduction |
|---|
|
|
|---|
Epidemiologic links between the increase of allergic respiratory disease and environmental air pollution have been well established (1). Diesel exhaust particles (DEP) are major air components of inhaled particulate pollution in the industrialized world. DEP and their polycyclic aromatic hydrocarbon components have been demonstrated to enhance IgE production in animals and humans both in vivo and in vitro (4). Combined intranasal challenge with DEP plus allergen induced a large increase in allergen-specific IgE in allergic subjects associated with a Th2-type cytokine profile including enhanced interleukin (IL)-4 and IL-13 production (8, 9). Human B cells have been shown to produce IgE following stimulation with either IL-4 or IL-13 plus CD40 or CD58 ligation (10) with both IL-4 and IL-13 acting as switch factors. We investigated whether in humans, mucosal DEP exposure could be shown to be involved in in vivo Ig isotype switching to IgE. Although earlier in vitro studies employing DEP alone failed to find evidence for induction of IgE isotype switching, the magnitude of the in vivo increase in allergen IgE suggested that allergen-responsive B cells, in the presence of DEP plus allergen, were undergoing isotype switching to IgE.
Ig isotype switching is the process whereby B cells initially expressing IgM and/or IgD on their surface rearrange the active encoding variable-diversity joint region to other Ig heavy chain loci and thereby provide antibodies with different effector functions but the same antigen specificity (15, 16). Molecular analyses of Ig isotype switching strongly supports a model of alignment of two switch (S) region sequences with looping out and deletion of the intervening DNA region (17). This model has been directly demonstrated by the identification of circular Ig switch DNA isolated from in vivo and in vitro stimulated human and mouse B cells (18).
Definitive proof of cells having been driven to undergo
isotype switching requires demonstration of the ability to
induce the appropriate deleted switch circular DNA.
Other measures of isotype switched cells, such as Ig producing cells, IgE protein levels, and even the presence of
isotype switched (rearranged) DNA cannot distinguish between recruitment of previously switched cells and cells
having just undergone isotype switching. Thus, in this
study we tested whether nasal challenge with DEP plus ragweed allergen was able to induce in vivo isotype switching to IgE in patients with ragweed allergy by determining
the production of circular switch DNA representing µ to
switching.
| |
Material and Methods |
|---|
|
|
|---|
Subjects
Eight healthy, nonsmoking volunteers (four men and four women), ranging in age from 21 to 36 yr, were recruited in Los Angeles, CA. All had a positive intracutaneous skin test to short ragweed (over 10 mm) and a history consistent with allergic rhinitis. While two of the eight subjects showed positive skin tests for other allergens, all were asymptomatic during the course of the study. The subjects did not take any medication for 3 d prior to or at any time during the duration of the study. The allergen used in this study, short ragweed, is not present in the Los Angeles area. No subject had been previously treated with immunotherapy for ragweed. Although the local Western ragweed cross-reacts with short ragweed, Western ragweed is a minor allergen in Los Angeles and was not pollinating during the time of this study. All studies were approved by the Human Subject Protection Committee of the University of California, Los Angeles.
All subjects in this study who were treated with intranasal challenge of the ragweed allergen Amb a I displayed an immediate allergic reaction. Challenge with both DEP and ragweed did not result in a significant increase of the symptom as compared with challenge with ragweed alone. Challenge with DEP alone did not result in symptoms (6).
Nasal Challenge of DEP and Allergen
All subjects were challenged on three different occasions with either ragweed alone, DEP alone, or DEP plus ragweed. At least 8 wk passed between challenges, which were performed in a random order. The method of nasal challenge with ragweed allergen alone has been described previously (6). Briefly, subjects were then challenged by spraying the nose with increasing doses of short ragweed Amb a I starting at 10 AU and increasing in 10-fold steps until immediate allergic symptoms were apparent or 1,000 AU had been administered. In two subsequent visits, each a minimum of 8 wk apart, subjects were randomly challenged with both DEP (0.3 mg) and ragweed allergen or with DEP alone. The doses of DEP were chosen according to previous reports (6, 9). DEP (0.15 mg) in 100 µl of saline was sprayed into each nostril for a total of 0.3 mg DEP.
For each subject, three nasal lavages were performed
prior to challenge on three different days; then three consecutive nasal lavages were performed 4 d following each
challenge. Thus, six nasal lavages were performed on each
subject. The methods for nasal lavage and challange have
previously been described in detail (6, 8, 9). Briefly, 5 ml of
normal saline was delivered into each nostril of the subjects
and after 10 s, the wash fluid was collected into a tube. The
subjects performed four subsequent nasal washes at 10-min
intervals. After the tubes were centrifuged at 350 × g for
10 min, the supernatants were transferred to other tubes
and stored at
20°C. The pellets of cells were stored at
20°C.
Isolation of Circular DNA
The cell pellets from nasal lavages were stored until all subjects had finished all their nasal challenges. After the frozen cells were thawed, all eight samples from the different subjects from the same kind and time of nasal challenge were combined into one tube on ice. This was necessary in order to achieve sufficient quantities of B cells and B-cell DNA. Initial attempts to isolate circular DNA from a cell pellet from a single patient obtained 4 d after a DEP-plus-ragweed challenge were unsuccessful because the amount of total circular DNA fraction recovered from a single challenge was extremely small (< 0.02 µg), such that amplified polymerase chain reaction (PCR) bands could not be seen. Therefore, we pooled the samples from the allergic subjects (n = 8) challenged under identical conditions so as to have adequate amounts of circular DNA fraction for each type of challenge. Samples were pooled because it was not possible to challenge the same patient multiple times; the challenge itself serves as an allergen exposure and would alter ("prime") subsequent challenges. Pooling different patient samples increased the amount of DNA assayed for switch circular DNA. There is no evidence that pooling samples would alter the performance or interpretation of the PCR data.
Circular DNA was prepared from the alkaline lysate of
the total cell pellets, as described previously (23). To
exclude the highly unlikely possibility of our findings resulting from DNA recombination via some undefined recombinase activity acting in vitro, the cell pellets were
boiled for 2 min before treatment with lysis buffer and isolation of circular DNA. The precipitated circular DNA
was digested with EcoR I, a critical step to linearize circular DNA, and then treated with ribonuclease for 2 h at
37°C to remove RNA. The Sµ and S
regions have no internal EcoR I sites while EcoR I sites are present in the 5'
and 3' sequences flanking the S regions (30, 31). Linearization of circular DNA provides for improved amplification
compared with undigested supercoiled DNA (23). After
linearization, the treated circular DNA was used as PCR
templates.
PCR Strategy to Detect Recombined S
/Sµ Sequences
Nested primer PCR runs for recombined S
/Sµ switch
fragments were performed on prepared linearized DNA
as described (23). Briefly, PCR was run in a 50-µl/reaction with 50 mM KCl, 20 mM Tris-HCl (pH 8.4), 1.5 mM
MgCl2, 5% dimethyl sulfoxide, 50 pmoles primer/reaction,
and 2.5 U of Taq polymerase. The PCR assays were carried out as 1 min denaturing (94°C), 1 min annealing (65°C on the first PCR, 68°C on the second), and 2 min extension
(72°C), for 40 cycles. The primer sequences have been
published elsewhere (23). The µ primers were located just
3' to the end of Sµ (31) while the
primers were located in
the I
region (32), which is just 5' to the S
sequence.
Cloning, Screening, and DNA Sequencing
The PCR products of switch circular DNA were cloned by
TA cloning (Invitrogen, San Diego, CA). Positive clones
were selected by hybridization with a 5'S
probe labeled
with [32P]
-cytidine triphosphate by random priming (23).
Hybridization was conducted according to the standard
methods, with hybridization in 50% formamide being performed at 42°C and the washing temperature for blots being 65°C. Nucleotide sequences were determined by the
standard dideoxyl chain termination method using a DNA
sequencing kit (Sequenase version 2.0; Amersham, Arlington Heights, IL).
Ig Measurements
Total IgE levels of nasal lavage were measured by enzyme-linked immunosorbent assays (ELISAs) as previously described (6, 11, 33), with minor modifications. The sensitivity of the assay for total IgE was 0.1 ng/ml. The samples were repeated if there was more than a 5% variation between them.
Ragweed-specific IgE were determined using the same procedure as for total Ig isotypes, except that an amplification system previously described (9) was used with minor modifications. The plates were cultured and coated with 10 µg/ml of ragweed extract standardized for its Amb a I content (Hollister Stier/Baxter, Spokane, WA), and alkaline phosphatase-labeled anti-IgE (Tago, Burlingame, CA) at 1/3,000 was used.
| |
Results |
|---|
|
|
|---|
Combined Nasal Challenge with DEP and
Allergen Induced S
/Sµ Switch Circles
Multiple DNA fragments were amplified by nested PCR
using linearized DNA from the DNA representing the
eight samples of nasal cells obtained 4 d following combined nasal challenge with DEP plus ragweed allergen
(Figure 1). No such DNA fragments could be amplified
from nasal cells obtained prior to challenge or from cells
obtained following challenge with DEP or ragweed alone. A number of the amplified fragments shown in Figure 1(I)
from DEP-plus-ragweed-stimulated cells hybridized with
an S
probe. No hybridizing bands were observed with the
S
probe in any of the pre-challenge samples or in samples
collected after challenge with ragweed alone or DEP
alone (Figure 1[II]). This result was not simply a reflection
of increased cell recovery in the combined challenge pellets because the total amount of DNA in the "circular DNA" preparation before PCR assay was not significantly
different among the three challenge protocols (DEP and
ragweed = 0.489 and 0.568 µg; ragweed alone = 0.510 and
0.581 µg; DEP alone = 0.412 and 0.612 µg; before and after nasal challenge, respectively). The DNA in our circular
DNA fraction may have contained some genomic DNA
because it is not possible to exclude genomic DNA completely in the process of circular DNA isolation. Peripheral blood B lymphocytes were obtained from three of the
study subjects on Day 4 following combined nasal challenge with DEP plus ragweed allergen. No S
/Sµ circular
DNA fragment could be amplified by nested PCR (data not shown).
|
|
The PCR products from the cells following challenge
with DEP plus ragweed allergen were cloned. A total of
six independent clones were isolated and sequenced (Figure 2). The structures of all six clones showed the predicted general structure of 5' S
sequence directly joined
to 3' Sµ sequence. As expected for isotype switching (19-
28), no consensus sequence was found at the S
/Sµ breakpoints.
|
In order to obtain an upper limit for the amount of S
/
Sµ cells that would have gone undetected, the ability of
our nested PCR assay to detect switch circular DNA was
assessed using a cloned plasmid containing an S
/Sµ fragment as previously described (25, 27). The S
/Sµ plasmid
was serially diluted and then used as a template for the
nested PCR assay. A band was detected on gel electrophoresis following PCR when there were between one and
10 copies of template present per reaction (data not
shown).
Effect of Nasal Challenge on Total and Ragweed-Specific IgE Levels
Consistent with our previous results, total IgE levels in nasal lavage were significantly increased following nasal challenge with DEP alone (before = 0.70 ± 0.46 ng/ml, after = 3.36 ± 1.60 ng/ml, P < 0.005, Figure 3A) (6, 8) or ragweed allergen alone (before = 0.88 ± 0.58 ng/ml, after = 6.04 ± 2.18 ng/ml, P < 0.005) (9). Combined challenge with ragweed allergen plus DEP also increased total IgE (before = 1.01 ± 0.56 ng/ml, after = 5.09 ± 2.63 ng/ml, P < 0.005). There was no significant difference between the total IgE levels among the three types of challenge. No enhancement in IgE was observed after saline challenge (data not shown; see Diaz-Sanchez and associates [6]).
Combined intranasal challenge with DEP and ragweed allergen induced a marked increase in the ragweed-specific IgE levels of nasal lavage (from 0.08 ± 0.06 U/ml to 4.01 ± 2.01 U/ml, P < 0.001) (Figure 3B). Challenge with ragweed alone also caused a significant increase in ragweed-specific IgE (before = 0.07 ± 0.06 U/ml, after = 2.34 ± 1.30 U/ml, P < 0.005). The increase in allergen-specific IgE levels after challenge with ragweed alone was significantly less than seen with combined DEP plus ragweed challenge (P < 0.05), reproducing previous findings (9). Nasal challenge with DEP alone had no effect on production of ragweed-specific IgE in the nose (before = 0.03 ± 0.05 U/ml, after = 0.03 ± 0.05 U/ml). There were no significant elevations of albumin levels over baseline values after all three forms of nasal challenge at Day 4 (data not shown).
| |
Discussion |
|---|
|
|
|---|
In this study we demonstrate for the first time the induction of in vivo isotype switching to IgE in humans. Following challenge of ragweed-allergic subjects with DEP plus
ragweed allergen, local in vivo production of circular switch
DNA, representing switching from µ to
, was detected.
We isolated, cloned, and sequenced S
/Sµ switch circular
DNA fragments as a direct demonstration that isotype
switching occurred in the nose. While we cannot completely exclude the possibility that IgE-switching B cells containing switch circles migrated into the nasal mucosa following
the combined challenge, no switch circles were detected in
four independent experiments using freshly isolated, unstimulated peripheral blood mononuclear cells from subjects following combined DEP-plus-ragweed challenge
(data not shown).
Our laboratory has previously established an in vivo
human model of a local allergic response induced by challenge with either allergen or DEP. We have shown that
challenge with an 0.3-mg dose of DEP, approximately
equivalent to breathing the outdoor air in Los Angeles for
a 24-h period on an average day, alters the regulation of
local IgE production in the human nose (6, 9). Isotype
switching to IgE in human B cells requires at least two signals (10). One signal, provided by IL-4 or IL-13, induces
germ-line transcripts from Ig heavy chain loci (11,
12, 32), which precede the occurrence of
isotype switching. Combined nasal challenge with DEP plus allergen has
been shown to result in a local Th2-type cytokine pattern
characterized by increased levels of messenger RNA
(mRNA) for IL-4, IL-5, IL-10, and IL-13, and decreased
interferon-
(8, 9). The second signal required for isotype
switching is a cell contact activation signal that can be provided by CD40-CD40L or CD58-CD2 interactions. Intratracheal injection of DEP and allergen in mice has been
shown to induce local T-cell activation which can account
for an increased CD40 ligand expression on T cells (34).
Thus, we tested whether nasal challenge with DEP plus allergen would result in suitable local conditions for the induction of isotype switching to IgE.
Numerous animal models have been established whereby
initial injection of adjuvant plus allergen, followed by repeated allergen exposure, induce
isotype switching in vivo.
Challenge of atopic subjects with allergen induces preferential activation of cells having a Th2-type cytokine mRNA
expression pattern characterized by the production of
IL-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor (35). However, in our system, nasal challenge with ragweed alone generated no switch circles in
nasal lavage cells, showing that the exposure of allergen
alone did not induce local isotype switching for IgE in the
nose. This result is likely due to the low level of allergen
challenge employed. We used a single exposure to ragweed in a dose that induced a minimum clinical reaction
and little induction of local cytokines in order to investigate the effect of DEP in vivo (9). Repeated intranasal allergen challenge has been shown to induce local in vivo
isotype switching in mice models (38). It is possible that
the minimum nasal allergen challenge employed triggered
antigen-specific B cells via cognate recognition and resulted in expansion of antigen-specific IgE cells. However,
this challenge was inadequate to drive the Th2-type cytokine dominant milieu necessary for generation of new isotype switching to IgE. In contrast, DEP challenge alone, a
potent non-cognate stimulus, enhanced a whole range of
cytokines (a Th0-type reaction) and caused an increase in
total IgE in the nasal lavage (8) but did not induce switch
circular DNA in nasal B cells. Together, DEP plus allergen likely provided the required cognate plus non-cognate
signals necessary to drive local B cells to undergo
isotype
switching in vivo. These results further support the concept that increasing environmental DEP with unchanged
levels of allergen could be a factor in the increasing clinical
sensitization and prevalence of allergic respiratory disease
observed over the past two centuries. It is also possible that DEP may not only enhance isotype switching and IgE
production but, in conjunction with an antigen, it may also
help to induce a de novo specific IgE mucosal response.
Research is currently underway to support this hypothesis.
| |
Footnotes |
|---|
Address correspondence to: Shigeharu Fujieda, M.D., Dept. of Otorhinolaryngology, Fukui Medical University, Shimoaizuki, Matsuoka, Yoshida, Fukui, 910-11, Japan. E-mail: sfujieda{at}fmsrsa.fukui-med.ac.jp
(Received in original form August 18, 1997 and in revised form February 2, 1998).
Acknowledgments: The authors thank Ms. Jennifer Fleming for her excellent technical assistance. This work was supported by United States Public Health Service Grants AI-15251; the UCLA Asthma, Allergy and Immunologic Disease Center (AI-34567) funded by the National Institute of Allergy and Infectious Disease and the National Institute of Environmental Health Science; and gifts from the Clemente Foundation, Sara and Robert LeBien, and the Allergy Research Foundation. This work was also supported by an Abroad Fellowship for Young Scientists to one author (S.F.) from the Ministry of Education, Science, Sports and Culture of Japan.
Abbreviations DEP, diesel exhaust particles; S, switch.
| |
References |
|---|
|
|
|---|
1. Takefuji, S., S. Suzuki, M. Muranaka, and T. Miyamoto. 1989. Influence of environmental factors on IgE production, IgE, mast cells, and the allergic response. Chiba Found. Symp. 147: 188-204 .
2. Bascom, R., T. Kulle, A. Kagey-Sobotka, and D. Proud. 1991. Upper respiratory tract environmental tobacco smoke sensitivity. Am. Rev. Respir. Dis. 143: 1304-1311 [Medline].
3. Corbo, G. M., F. Forastiere, V. Dell'Orco, R. Pistelli, N. Agabiti, B. D. Stefanis, G. Ciappi, and C. A. Perucci. 1993. Effects of environment on atopic status and respiratory disorders in children. J. Allergy Clin. Immunol. 92: 616-623 [Medline].
4. Muranaka, M., S. Suzuki, K. Koizumi, S. Takafuji, T. Miyamoto, R. Ikemori, and H. Tokiwa. 1986. Adjuvant activity of diesel-exhaust particulates for the production of IgE antibody in mice. J. Allergy Clin. Immunol. 77: 616-623 [Medline].
5. Takafuji, S., S. Suzuki, K. Koizumi, K. Tadokoro, T. Miyamoto, R. Ikemori, and M. Muranaka. 1987. Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J. Allergy Clin. Immunol. 79: 639-645 [Medline].
6. Diaz-Sanchez, D., A. R. Dotson, H. Takenaka, and A. Saxon. 1994. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J. Clin. Invest. 94: 1417-1425 .
7. Takenaka, H., K. Zhang, D. Diaz-Sanchez, A. Tsien, and A. Saxon. 1995. Enhanced human IgE production results from exposure to aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J. Allergy Clin. Immunol. 95: 103-115 [Medline].
8. Diaz-Sanchez, D., A. Tsien, A. Casillas, A. R. Dotson, and A. Saxon. 1996. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J. Allergy Clin. Immunol. 98: 114-123 [Medline].
9. Diaz-Sanchez, D., A. Tsien, J. Fleming, and A. Saxon. 1997. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhanced in vivo nasal ragweed-specific IgE and skews cytokine production to a TH2-type pattern. J. Immunol. 158: 2406-2413 [Abstract].
10.
Jabara, H. H.,
S. M. Fu,
R. S. Geha, and
D. Vercelli.
1990.
CD40 and IgE:
synergism between anti-CD40 monoclonal antibody and interleukin 4 in
the induction of IgE synthesis by highly purified human B cells.
J. Exp.
Med
172:
1861-1864
11.
Zhang, K.,
E. A. Clark, and
A. Saxon.
1991.
CD40 stimulation provides an
IFN-
-independent and IL-4-dependent differentiation signal directly to
human B cells for IgE production.
J. Immunol
146:
1836-1842
[Abstract].
12.
Punnonen, J.,
G. Aversa,
B. G. Cocks,
A. N. J. McKenzie,
S. Menon,
G. Zurawski,
R. W. Malefyt, and
J. E. de Vries.
1993.
Interleukin-13 induces
interleukin 4-independent IgG4 and IgE synthesis and CD23 expression
by human B cells.
Proc. Natl. Acad. Sci. USA
90:
3730-3734
13. Diaz-Sanchez, D., S. Chegini, K. Zhang, and A. Saxon. 1994. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. J. Immunol. 153: 10-20 [Abstract].
14.
Kimata, H.,
M. Fujimoto,
C. Ishioka, and
A. Yoshida.
1996.
Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production
induced by anti-CD58 monoclonal antibody.
J. Exp. Med.
184:
357-364
15. Esser, C., and A. Radbruch. 1990. Immunoglobulin class switching: molecular and cellular analysis. Annu. Rev. Immunol 8: 717-735 [Medline].
16. Yuan, R., A. Casadevall, G. Spira, and M. D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154: 1810-1816 [Abstract].
17.
Honjo, T., and
T. Kataoka.
1978.
Organization of immunoglobulin heavy
chain genes and allelic deletion model.
Proc. Natl. Acad. Sci. USA
75:
2140-2144
18. Schwedler, U. V., H. M. Jack, and M. Wabl. 1990. Circular DNA is a product of the immunoglobulin class switch rearrangement. Nature 345: 452-456 [Medline].
19. Matsuoka, M., K. Yoshida, T. Maeda, S. Usuda, and H. Sakano. 1990. Switch circular DNA formed in cytokine-treated mouse splenocytes: evidence for intramolecular DNA deletion in immunoglobulin class switch. Cell 62: 135-142 [Medline].
20. Iwasato, T., A. Shimizu, T. Honjo, and H. Yamagishi. 1990. Circular DNA is excised by immunoglobulin class switch recombination. Cell 62: 143-149 [Medline].
21.
Yoshida, K.,
M. Matsuoka,
S. Usuda,
A. Mori,
K. Ishizaka, and
H. Sakano.
1990.
Immunoglobulin switch circular DNA in the mouse infected with
Nippostrongylus brasiliensis: evidence for successive class switching from
µ to
via
1.
Proc. Natl. Acad. Sci. USA
87:
7829-7833
22.
Iwasato, T.,
H. Arakawa,
A. Shimizu,
T. Honjo, and
H. Yamagishi.
1992.
Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor
and lipopolysaccharide.
J. Exp. Med
175:
1539-1546
23.
Zhang, K.,
F. C. Mills, and
A. Saxon.
1994.
Switch circles from IL-4-directed
class switching from human B lymphocytes: evidence for direct, sequential, and multiple step sequential switch from µ to
Ig heavy chain gene.
J.
Immunol
152:
3427-3435
[Abstract].
24.
Fujieda, S.,
K. Zhang, and
A. Saxon.
1995.
IL-4 plus CD40 monoclonal antibody induces human B cells
subclass specific isotype switching: switching
to
1,
3, and
4, but not
2.
J. Immunol.
155:
2318-2328
[Abstract].
25.
Fujieda, S.,
J. A. Wasschek,
K. Zhang, and
A. Saxon.
1996.
Vasoactive intestinal peptide induces S
/Sµ switch circular DNA in human B cells.
J.
Clin. Invest.
98:
1527-1532
[Medline].
26.
Malisan, F.,
F. Brière,
J. M. Brindon,
N. Harindranath,
F. C. Mills,
E. E. Max,
J. Banchereau, and
H. M. Valdez.
1996.
Interleukin-10 induces immunoglobulin in human CD40-activated naive B lymphocytes.
J. Exp.
Med.
183:
937-947
27. Fujieda, S., Y. Q. Lin, A. Saxon, and K. Zhang. 1996. Multiple types of chimeric germ-line immunoglobulin heavy chain transcripts in human B cells: evidence for trans-splicing of human immunoglobulin RNA. J. Immunol. 157: 3450-3459 [Abstract].
28.
Fujieda, S.,
A. Saxon, and
K. Zhang.
1996.
Direct evidence that
1 and
3
switching in human B cells is interleukin-10 dependent.
Mol. Immunol.
33:
1335-1343
[Medline].
29.
Griffin, B. E.,
E. Björck,
G. Bjursell, and
T. Lindahl.
1981.
Sequence complexity of circular Epstein-Barr virus DNA in transformed cells.
J. Virol.
40:
11-19
30.
Flanagan, J. G., and
T. H. Rabbitts.
1982.
Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing
,
, and
genes.
Nature
300:
709-713
[Medline].
31.
Mills, F. C.,
J. S. Brooker, and
R. D. Camerini-Otero.
1990.
Sequences of
human immunoglobulin switch regions: implications for recombination and
transcription.
Nucleic Acids Res.
18:
7305-7316
32.
Gauchat, J. F.,
D. A. Lebman,
R. L. Coffman,
H. Gascan, and
J. E. de Vries.
1990.
Structure and expression of germ-line
transcripts in human B cells
induced by interleukin 4 to switch to IgE production.
J. Exp. Med.
172:
463-473
33. Macy, E., D. M. Kemeny, and A. Saxon. 1988. Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. FASEB J. 2: 3003-3010 [Abstract].
34. Fujimaki, H., O. Nohara, T. Ichinose, N. Watanabe, and S. Saito. 1994. IL-4 production in mediastinal lymph node cells in mice intratracheally instilled with diesel exhaust particles and antigen. Toxicology 92: 261-268 [Medline].
35.
Kay, A. B.,
S. Ying,
V. Varney,
M. Gega,
S. R. Durham,
R. Moqbel,
A. J. Wardlaw, and
Q. Hamid.
1991.
Messenger RNA expression of cytokine
gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage
colony-stimulating reactions in atopic subjects.
J. Exp. Med.
173:
775-778
36. Durham, S. R., S. Ying, V. A. Varney, M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay, and Q. A. Hamid. 1992. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148: 2390-2394 [Abstract].
37. Terada, N., A. Konno, S. Fukuda, T. Yamashita, K. Shiratori, Y. Okamoto, K. Ishikawa, and K. Togawa. 1994. Interleukin-5 expression in nasal mucosa and challenge in amount of interleukin-5 in nasal lavage fluid after antigen challenge. Acta Otolaryngol. 114: 203-208 [Medline].
38.
Toellner, K.-M.,
A. Gulbranson-Judge,
D. R. Taylor,
D. M.-Y. Sze, and
I. C. M. Maclennan.
1996.
Immunoglobulin switch transcript production in
vivo related to site and time of antigen-specific B cell activation.
J. Exp.
Med.
183:
2303-2312
This article has been cited by other articles:
![]() |
J. Liu, M. Ballaney, U. Al-alem, C. Quan, X. Jin, F. Perera, L.-C. Chen, and R. L. Miller Combined Inhaled Diesel Exhaust Particles and Allergen Exposure Alter Methylation of T Helper Genes and IgE Production In Vivo Toxicol. Sci., March 1, 2008; 102(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wan and D. Diaz-Sanchez Phase II Enzymes Induction Blocks the Enhanced IgE Production in B Cells by Diesel Exhaust Particles. J. Immunol., September 1, 2006; 177(5): 3477 - 3483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ciencewicki, L. Brighton, W.-D. Wu, M. Madden, and I. Jaspers Diesel exhaust enhances virus- and poly(I:C)-induced Toll-like receptor 3 expression and signaling in respiratory epithelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1154 - L1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schober, B. Belloni, S. Lubitz, B. Eberlein-Konig, P. Bohn, Y. Saritas, J. Lintelmann, G. Matuschek, H. Behrendt, and J. Buters Organic Extracts of Urban Aerosol (<=PM2.5) Enhance rBet v 1-Induced Upregulation of CD63 in Basophils from Birch Pollen-Allergic Individuals Toxicol. Sci., April 1, 2006; 90(2): 377 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Dong, X. J. Yin, J. Y. C. Ma, L. Millecchia, M. W. Barger, J. R. Roberts, X.-D. Zhang, J. M. Antonini, and J. K. H. Ma Exposure of Brown Norway Rats to Diesel Exhaust Particles Prior to Ovalbumin (OVA) Sensitization Elicits IgE Adjuvant Activity but Attenuates OVA-Induced Airway Inflammation Toxicol. Sci., November 1, 2005; 88(1): 150 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Haar, I. Hassing, M. Bol, R. Bleumink, and R. Pieters Ultrafine Carbon Black Particles Cause Early Airway Inflammation and Have Adjuvant Activity in a Mouse Allergic Airway Disease Model Toxicol. Sci., October 1, 2005; 87(2): 409 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Kang, A.-S. Jang, M.-H. Ahn, J.-A. Shin, J.-H. Kim, Y.-S. Choi, T.-Y. Rhim, and C.-S. Park Interleukin-25 and Interleukin-13 Production by Alveolar Macrophages in Response to Particles Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 290 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Takhar, L. Smurthwaite, H. A. Coker, D. J. Fear, G. K. Banfield, V. A. Carr, S. R. Durham, and H. J. Gould Allergen Drives Class Switching to IgE in the Nasal Mucosa in Allergic Rhinitis J. Immunol., April 15, 2005; 174(8): 5024 - 5032. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohtani, S. Nakagawa, M. Kurosawa, M. Mizuashi, M. Ozawa, and S. Aiba Cellular Basis of the Role of Diesel Exhaust Particles in Inducing Th2-Dominant Response J. Immunol., February 15, 2005; 174(4): 2412 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Miller, R. Garfinkel, M. Horton, D. Camann, F. P. Perera, R. M. Whyatt, and P. L. Kinney Polycyclic Aromatic Hydrocarbons, Environmental Tobacco Smoke, and Respiratory Symptoms in an Inner-city Birth Cohort Chest, October 1, 2004; 126(4): 1071 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Lee, J.-W. Liao, and J.-J. Kang Motorcycle Exhaust Particles Induce Airway Inflammation and Airway Hyperresponsiveness in BALB/C Mice Toxicol. Sci., June 1, 2004; 79(2): 326 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Marshall Internal and External Environmental Influences in Allergic Diseases J Am Osteopath Assoc, May 1, 2004; 104(5_suppl): 1S - 6S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cameron, A. S. Gounni, S. Frenkiel, F. Lavigne, D. Vercelli, and Q. Hamid S{epsilon}S{micro} and S{epsilon}S{gamma} Switch Circles in Human Nasal Mucosa Following Ex Vivo Allergen Challenge: Evidence for Direct as Well as Sequential Class Switch Recombination J. Immunol., October 1, 2003; 171(7): 3816 - 3822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Senechal, P. de Nadai, N. Ralainirina, A. Scherpereel, H. Vorng, P. Lassalle, A.-B. Tonnel, A. Tsicopoulos, and B. Wallaert Effect of Diesel on Chemokines and Chemokine Receptors Involved in Helper T Cell Type 1/Type 2 Recruitment in Patients with Asthma Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 215 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reibman, Y. Hsu, L. C. Chen, A. Kumar, W. C. Su, W. Choy, A. Talbot, and T. Gordon Size Fractions of Ambient Particulate Matter Induce Granulocyte Macrophage Colony-Stimulating Factor in Human Bronchial Epithelial Cells by Mitogen-Activated Protein Kinase Pathways Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fahy, S. Senechal, J. Pene, A. Scherpereel, P. Lassalle, A.-B. Tonnel, H. Yssel, B. Wallaert, and A. Tsicopoulos Diesel Exposure Favors Th2 Cell Recruitment by Mononuclear Cells and Alveolar Macrophages from Allergic Patients by Differentially Regulating Macrophage-Derived Chemokine and IFN-{gamma}-Induced Protein-10 Production J. Immunol., June 1, 2002; 168(11): 5912 - 5919. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Granum and M. Lovik The Effect of Particles on Allergic Immune Responses Toxicol. Sci., January 1, 2002; 65(1): 7 - 17. [Full Text] [PDF] |
||||
![]() |
D. R. WILSON, T. G. MERRETT, E. M. VARGA, L. SMURTHWAITE, H. J. GOULD, M. KEMP, J. HOOPER, S. J. TILL, and S. R. DURHAM Increases in Allergen-Specific IgE in BAL after Segmental Allergen Challenge in Atopic Asthmatics Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 22 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sydbom, A. Blomberg, S. Parnia, N. Stenfors, T. Sandstrom, and S-E. Dahlen Health effects of diesel exhaust emissions Eur. Respir. J., April 1, 2001; 17(4): 733 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. FUJIEDA, S. IHO, Y. KIMURA, H. YAMAMOTO, H. IGAWA, and H. SAITO Synthetic Oligodeoxynucleotides Inhibit IgE Induction in Human Lymphocytes Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 232 - 239. [Abstract] [Full Text] |
||||
![]() |
S. FUJIEDA, S. IHO, Y. KIMURA, H. SUNAGA, H. IGAWA, C. SUGIMOTO, S. YAMAMOTO, and H. SAITO DNA from Mycobacterium bovis Bacillus Calmette-Guerin (MY-1) Inhibits Immunoglobulin E Production by Human Lymphocytes Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2056 - 2061. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. |